Preliminary study on glucose control with an artificial pancreas in postoperative sepsis patients

European Surgical Research

Volumn 47, Issue 1, 2011, Pages 32-38

  Takahashi, G ^a   Sato, N ^a   Matsumoto, N ^a   Shozushima, T ^a   Hoshikawa, K ^a   Akitomi, S ^a   Kikkawa, T ^a   Onodera, C ^a   Kojika, M ^a   Inoue, Y ^a   Suzuki, K ^a   Wakabayashi, G ^a   Endo, S ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Artificial pancreas; Glucose control; Hypoglycemia; Insulin; Sepsis

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG MEGADOSE; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; LOW DRUG DOSE; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS;

AGED; BLOOD GLUCOSE; FEMALE; GLUCOSE; HUMANS; HYPOGLYCEMIA; INSULIN; MALE; MIDDLE AGED; PANCREAS, ARTIFICIAL; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SEPSIS;

EID: 79955917624     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000327971     Document Type: Article

References (18)

1. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1367.
2. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM: Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858-872.
3. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buission C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
4. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297.
5. Kono T, Hanazaki K, Yazawa K, Ashizawa S, Fisher WE, Wang XP, Nose Y, Brunicardi FC, Debakey ME: Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs. Artif Organs 2005; 29: 83-87. (Pubitemid 41602009)
6. Okabayashi T, Hanazaki K, Nishimori I, Sugimoto T, Maeda H, Yatabe T, Dabanaka K, Kobayashi M, Yamashita K: Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. Dig Dis Sci 2008; 53: 1405-1410. (Pubitemid 351514618)
7. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829. (Pubitemid 15250137)
8. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med 1996; 22: 707-710. (Pubitemid 26254283)
9. The American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-1655.
10. The ARDS Network: Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2000; 283: 1995-2002.
11. Krinsley JS: Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79: 992-1000.
12. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandtb P, Macleod K, Laakso M, Torp-Pedersen C, Waldenstrom A: Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26: 650-661. (Pubitemid 40516876)
13. Brunkhorst FM, Engel C, Bloos F, Meier- Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-139.
14. Vanhorebeek I, Langouche L, Van den Berghe G: Tight glucose control: what is the evidence? Crit Care Med 2007; 35: 496-502.
15. Vriesendorp TM, Devries JH, Hoekstra JB: Hypoglycemia and strict glycemic control in critically ill patients. Curr Opin Crit Care 2008; 14: 397-402.
16. Hanazaki K, Maeda H, Okabayashi T: Tight perioperative glycemic control using an artificial endocrine pancreas. Surg Today 2010; 40: 1-7.
17. Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhyay A, Calieri J, Hoffmeyer D, Syed T, Ghanim H, Aljada A, Dandona P: Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 2004; 109: 849-854. (Pubitemid 38252736)
18. Dandona P, Mohanty P, Chaudhuri A, Garg R, Aljada A: Insulin infusion in acute illness. J Clin Invest 2005; 115: 2277-2286.